NASDAQ: REGN
Regeneron Pharmaceuticals, Inc.
Healthcare · Biotechnology
After hours: $667.17(0%) · as of 5:23 PM ET
Market Cap
$68.73B
52w High
$821.11
52w Low
$541.00
P/E
16.24
Volume
637.63K
Outstanding Shares
103.02M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 19.43% over the last year. Revenue grew 5.92% over the trailing twelve months. Operating margin moved from 27.2% to 24.32%. Free cash flow grew 37.58% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 21st percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 24.32%. Revenue grew 5.92% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
34
Buy
15
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 30, 2026
Q3 FY26 · EPS est $10.21 · Revenue est $3.82B
View
Dividends
$3.64/shareQuarterlySafeREGN pays a dividend with a 0.55% dividend yield, covered 11.0× by free cash flow.
Dividend Yield
0.55%
Annual Div / Share
$3.64
CAGR
—
Payout Ratio
8.46%
Safe
Dividend Growth Rate
Income Projection
Today
$0/mo
In 5 yrs
$0/mo
In 10 yrs
$0/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$5/yr $0/mo | $5/yr $0/mo | $5/yr $0/mo |
Analysis
Dividend Strengths
Well-covered by free cash flow
The dividend is covered 11.0× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.